Meeder Asset Management Inc Regeneron Pharmaceuticals, Inc. Transaction History

Meeder Asset Management Inc

  • $1.62 Billion
  • Q2 2025

A detailed history of Meeder Asset Management Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Meeder Asset Management Inc holds 5,636 shares of REGN stock, worth $3.16 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
5,636
Previous 20 28080.0%
Holding current value
$3.16 Million
Previous $12,000 24550.0%
% of portfolio
0.18%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025
BUY
$483.07 - $625.6 $2.71 Million - $3.51 Million
5,616 Added 28080.0%
5,636 $2.96 Million
Q1 2025

May 07, 2025
SELL
$634.14 - $744.83 $6,341 - $7,448
-10 Reduced 33.33%
20 $12,000
Q4 2024

Feb 12, 2025
SELL
$701.85 - $1046.91 $122,121 - $182,162
-174 Reduced 85.29%
30 $21,000
Q3 2024

Nov 07, 2024
BUY
$1024.09 - $1201.76 $181,263 - $212,711
177 Added 655.56%
204 $214,000
Q2 2024

Aug 08, 2024
SELL
$883.2 - $1071.19 $189,004 - $229,234
-214 Reduced 88.8%
27 $28,000
Q1 2024

May 07, 2024
BUY
$902.69 - $993.35 $217,548 - $239,397
241 New
241 $231,000
Q2 2023

Aug 11, 2023
SELL
$700.03 - $830.35 $3.37 Million - $3.99 Million
-4,811 Reduced 99.67%
16 $11,000
Q1 2023

May 15, 2023
SELL
$680.49 - $826.97 $22,456 - $27,290
-33 Reduced 0.68%
4,827 $3.97 Million
Q4 2022

Feb 14, 2023
SELL
$705.89 - $766.39 $855,538 - $928,864
-1,212 Reduced 19.96%
4,860 $3.51 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $586,023 - $739,530
-1,021 Reduced 14.39%
6,072 $4.18 Million
Q2 2022

Aug 08, 2022
BUY
$548.35 - $738.84 $334,493 - $450,692
610 Added 9.41%
7,093 $4.19 Million
Q1 2022

May 10, 2022
SELL
$595.12 - $698.43 $4.83 Million - $5.66 Million
-8,108 Reduced 55.57%
6,483 $4.53 Million
Q4 2021

Feb 11, 2022
SELL
$543.48 - $670.97 $1.19 Million - $1.47 Million
-2,192 Reduced 13.06%
14,591 $9.22 Million
Q3 2021

Nov 08, 2021
BUY
$574.03 - $680.96 $898,356 - $1.07 Million
1,565 Added 10.28%
16,783 $10.2 Million
Q2 2021

Aug 09, 2021
SELL
$472.8 - $558.54 $879,408 - $1.04 Million
-1,860 Reduced 10.89%
15,218 $8.5 Million
Q1 2021

Apr 28, 2021
BUY
$446.73 - $548.2 $7.45 Million - $9.15 Million
16,682 Added 4212.63%
17,078 $8.08 Million
Q4 2020

Feb 09, 2021
SELL
$478.3 - $607.98 $2.12 Million - $2.69 Million
-4,429 Reduced 91.79%
396 $191,000
Q3 2020

Nov 02, 2020
BUY
$544.75 - $658.21 $34,864 - $42,125
64 Added 1.34%
4,825 $2.7 Million
Q2 2020

Aug 11, 2020
SELL
$493.32 - $643.92 $4,439 - $5,795
-9 Reduced 0.19%
4,761 $2.97 Million
Q1 2020

May 15, 2020
SELL
$336.18 - $494.43 $1.72 Million - $2.52 Million
-5,102 Reduced 51.68%
4,770 $2.33 Million
Q4 2019

Feb 13, 2020
BUY
$274.13 - $376.51 $2.52 Million - $3.47 Million
9,204 Added 1377.84%
9,872 $3.71 Million
Q3 2019

Oct 17, 2019
SELL
$273.46 - $318.39 $100,906 - $117,485
-369 Reduced 35.58%
668 $185,000
Q2 2019

Aug 05, 2019
SELL
$299.6 - $414.82 $3.98 Million - $5.51 Million
-13,279 Reduced 92.76%
1,037 $325,000
Q1 2019

Apr 16, 2019
BUY
$372.08 - $439.57 $498,959 - $589,463
1,341 Added 10.34%
14,316 $5.88 Million
Q4 2018

Jan 17, 2019
BUY
$335.82 - $403.04 $1.63 Million - $1.96 Million
4,858 Added 59.85%
12,975 $4.85 Million
Q3 2018

Nov 02, 2018
BUY
$351.14 - $408.51 $2.26 Million - $2.63 Million
6,426 Added 380.01%
8,117 $0
Q2 2018

Jul 24, 2018
BUY
$284.6 - $344.99 $227,395 - $275,647
799 Added 89.57%
1,691 $0
Q1 2018

May 03, 2018
SELL
$315.82 - $393.78 $179,069 - $223,273
-567 Reduced 38.86%
892 $307,000
Q4 2017

Feb 02, 2018
SELL
$358.63 - $469.95 $595,684 - $780,586
-1,661 Reduced 53.24%
1,459 $549,000
Q3 2017

Oct 20, 2017
BUY
$431.38 - $504.0 $1.35 Million - $1.57 Million
3,120
3,120 $1.4 Million

Others Institutions Holding REGN

# of Institutions
1,425
Shares Held
85.2M
Call Options Held
1.39M
Put Options Held
1.42M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $60B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email